The global pan-genomic & multi-gene panel testing market size was estimated at USD 8.96 billion in 2024 and is projected to reach USD 23.19 billion by 2033, growing at a CAGR of 11.37% from 2025 to 2033, driven by driven by clinical adoption in oncology and precision medicine and inc... Read More »
December 2025The global hematocrit testing market size was estimated at USD 1.25 billion in 2024 and is projected to reach USD 2.01 billion by 2033, growing at a CAGR of 5.30% from 2025 to 2033, driven by a rising prevalence of hematological and chronic diseases, including anemia, blood loss monitori... Read More »
November 2025The Middle East liquid biopsy market size was valued at USD 104.76 million in 2024 and is projected to reach USD 233.95 billion by 2033, growing at a CAGR of 9.28% from 2025 to 2033. The market is driven by increased emphasis on early detection and population-level screening initiatives ... Read More »
November 2025The global antinuclear antibody test market size was estimated at USD 1.76 billion in 2024 and is projected to reach USD 5.47 billion by 2033, growing at a CAGR of 13.49% from 2025 to 2033. The market growth is accelerated by advancements in antinuclear antibody test (ANA) diagnostics, a... Read More »
November 2025The global endocrine function diagnostics market size was estimated at USD 13.16 billion in 2024 and is projected to reach USD 26.23 billion by 2033, growing at a CAGR of 8.0% from 2025 to 2033. The growing prevalence of endocrine disorders, strong shift towards precision diagnostics, an... Read More »
November 2025The global HPV testing and Pap test market size was estimated at USD 3.34 billion in 2024 and is projected to reach USD 6.18 billion by 2033, growing at a CAGR of 7.2% from 2025 to 2033. Technological advancements in testing products, increasing prevalence of cervical cancer, and governm... Read More »
November 2025The global hereditary testing market size was estimated at USD 16.16 billion in 2024 and is projected to reach USD 52.66 billion by 2033, growing at a CAGR of 14.42% from 2025 to 2033, due to the increasing prevalence of genetic disorders and related chronic conditions. As mor... Read More »
November 2025The global mycoplasma testing market size was estimated at USD 1.03 billion in 2024 and is expected to reach USD 2.81 billion in 2033, growing at a CAGR of 11.94% from 2025 to 2033. The rising investments in research and development (R&D) across the life sciences sector are a signifi... Read More »
November 2025The global cellular health screening market size was estimated at USD 3.30 billion in 2024 and is projected to reach USD 7.41 billion by 2033, growing at a CAGR of 9.5% from 2025 to 2033. An aging global population and the prevalence of age-related chronic diseases drive the market growt... Read More »
November 2025The global diagnostic reagents for infectious diseases market size was estimated at USD 3,475.31 million in 2024 and is projected to reach USD 8,079.07 million by 2033, growing at a CAGR of 9.30% from 2025 to 2033. The market is primarily driven by the increasing prevalence of respirator... Read More »
November 2025The global CRISPR-based POC diagnostics market size was estimated at USD 502.64 million in 2024 and is projected to reach USD 1,786.56 million by 2033, growing at a CAGR of 15.41% from 2025 to 2033. The market is expanding as diagnostic capabilities shift closer to the point of care, sup... Read More »
November 2025The global rapid pathogen detection diagnostics market size was estimated at USD 21.05 billion in 2024 and is projected to reach USD 30.90 billion by 2033, growing at a CAGR of 4.48% from 2025 to 2033. The growth is driven by growing demand for point-of-care testing, rising awareness and... Read More »
November 2025The Middle East antinuclear antibody test market size was valued at USD 36.35 million in 2024 and is projected to reach USD 113.83 million by 2033, growing at a CAGR of 13.6% from 2025 to 2033. The rising prevalence of autoimmune disorders, adoption of advanced testing technologies, incr... Read More »
November 2025The global genetic disease diagnostics market size was estimated at USD 11.71 billion in 2024 and is projected to reach USD 57.83 billion by 2033, growing at a CAGR of 19.1% from 2025 to 2033. The market is primarily driven by technological advancements, increasing demand for personalize... Read More »
November 2025The global acute respiratory disease diagnostics market size was estimated at USD 5.49 billion in 2024 and is projected to reach USD 10.71 billion by 2033, growing at a CAGR of 7.01% from 2025 to 2033. Some of the major factors driving the market are rising disease burden of respiratory ... Read More »
November 2025The Middle East cancer and tumor marker assays market size was estimated at USD 228.74 million in 2024 and is expected to reach USD 579.12 million by 2033, growing at a CAGR of 11.66% from 2025 to 2033. The rising incidence of cancer in the Middle East, growing awareness through campaign... Read More »
November 2025The Middle East renal biomarkers market size was estimated at USD 191.23 million in 2024 and is projected to reach USD 399.33 million by 2033, growing at a CAGR of 8.67% from 2025 to 2033. The burden of kidney disease is increasing steadily across the Middle East, driven by high rates of... Read More »
November 2025The Middle East imaging biomarkers market size was estimated at USD 413.74 million in 2024 and is projected to reach USD 1,131.80 million by 2033, growing at a CAGR of 12.27% from 2025 to 2033. The expansion of advanced imaging infrastructure (MRI, PET/CT) and the greater adoption of bio... Read More »
November 2025The global C-reactive protein testing market size was estimated at USD 5.27 billion in 2024, and is projected to reach USD 6.08 billion by 2033, growing at a CAGR of 1.64% from 2025 to 2033, due to the increasing demand for precision medicine. C-reactive protein is an acute-phase reactan... Read More »
November 2025The global newborn screening market size was estimated at USD 900.63 million in 2024 and is projected to reach USD 1,797.38 million by 2033, growing at a CAGR of 8.1% from 2025 to 2033. The rising neonatal population, increasing cases of congenital diseases in newborns, growing consumer ... Read More »
November 2025